A Study of Abiraterone in Combination With SHR3162 in the Treatment of mCRPC

NCT04108247 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Prostate Cancer Castration-resistant Prostate Cancer

Interventions

DRUG: Abiraterone+SHR3162

Sponsor

Jiangsu HengRui Medicine Co., Ltd.